Epigenetic Therapy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. (NCT01928576) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-11-06 |
Track Epigenetic Therapy automatically
Every clearance here is in the API, with alerts when new ones post.